ABSTRACT Nicotine, the primary psychoactive component in tobacco smoke, produces its behavioral effects through interactions with neuronal nicotinic acetylcholine receptors (nAChRs). a4b2 nAChRs are the most abundant in mammalian brain, and converging evidence shows that this subtype mediates the rewarding and reinforcing effects of nicotine. A number of rare variants in the CHRNA4 gene that encode the a4 nAChR subunit have been identified in human subjects and appear to be underrepresented in a cohort of smokers. We compared three of these variants (a4R336C, a4P451L, and a4R487Q) to the common variant to determine their effects on a4b2 nAChR pharmacology. We examined [ 3 H]epibatidine binding, interacting proteins, and phosphorylation of the a4 nAChR subunit with liquid chromatography and tandem mass spectrometry (LC-MS/ MS) in HEK 293 cells and voltage-clamp electrophysiology in Xenopus laevis oocytes. We observed significant effects of the a4 variants on nAChR expression, subcellular distribution, and sensitivity to nicotine-induced receptor upregulation. Proteomic analysis of immunopurified a4b2 nAChRs incorporating the rare variants identified considerable differences in the intracellular interactomes due to these single amino acid substitutions. Electrophysiological characterization in X. laevis oocytes revealed alterations in the functional parameters of activation by nAChR agonists conferred by these a4 rare variants, as well as shifts in receptor function after incubation with nicotine. Taken together, these experiments suggest that genetic variation at CHRNA4 alters the assembly and expression of human a4b2 nAChRs, resulting in receptors that are more sensitive to nicotine exposure than those assembled with the common a4 variant. The changes in nAChR pharmacology could contribute to differences in responses to smoked nicotine in individuals harboring these rare variants.
Introduction
Nicotine, the principle psychoactive component of tobacco, exerts its effects through interactions with neuronal nicotinic acetylcholine receptors (nAChRs). The principal class of nAChRs that binds nicotine with high affinity in the mammalian central nervous system (CNS) is the a4b2*-nAChR family (Picciotto et al., 1995; Millar and Gotti, 2009 ) (* designates potential additional subunits) (Lukas et al., 1999) . Experiments with transgenic mice lacking b2* nAChRs (Picciotto et al., 1995 (Picciotto et al., , 1998 , cell type-selective knockout of the a4 nAChR subunit (McGranahan et al., 2011) , and knock-in mice with hypersensitive a4 nAChR subunits (Tapper et al., 2004 (Tapper et al., , 2007 demonstrated that activation of a4b2* nAChRs was necessary and sufficient for many behavioral effects associated with nicotine addiction. This has led recent genetic association studies to focus on nAChR subunit genes as targets of interest. A metaanalysis of nicotine dependence linkage studies supported significant genomewide linkage with a related trait at a chromosomal region overlying the CHRNA4 locus (Han et al., 2010) , and association studies found significant effects of several CHRNA4 variants on nicotine dependence (Han et al., 2011; Kamens et al., 2013) . A polymorphism in the a5 nAChR subunit gene (CHRNA5) (Bierut et al., 2008) has received particular attention, because it is consistently associated with nicotine dependence and produces an amino acid substitution (D397N) that results in altered function of a4b2a5 nAChRs (Bierut et al., 2008; Kuryatov et al., 2011) .
Rare variants in CHRNA4 also appear to be underrepresented among smokers (Xie et al., 2011) . A particular rare variant (a4P451L) has also been associated with development of amyotrophic lateral sclerosis (ALS) (Sabatelli et al., 2009 (Sabatelli et al., , 2012 , suggesting that it may be of particular functional interest. In the current study, we characterize a subset of rare variants in the CHRNA4 gene that alter amino acid sequence of the subunit. We chose polymorphisms based on a bioinformatic screen of predicted shifts in short linear interaction motifs relative to the wild-type subunit. We examined the effects of a4R336C, a4P451L, and a4R487Q on nAChR expression and protein/protein interaction in HEK 293 cells as well as receptor activation in X. laevis oocytes.
Materials and Methods
cDNA and Chemicals. Mutations corresponding to the identified rare variants were introduced into a human a4 cDNA (ha4) construct in a psp64-polyA vector (Promega, Madison, WI) using GeneArt SiteDirected Mutagenesis (Invitrogen, Carlsbad, CA) . Except where noted, all chemicals were obtained from Sigma-Aldrich (St. Louis, MO). [ ]epibatidine binding to cell membranes and solubilized receptors was performed as detailed in Supplemental Methods. Except where indicated, specific counts per minute were converted to femtomoles and normalized further to the total protein content present in each sample to provide units of femtomoles per milligramsprotein. Quantitation of plasma membrane a4b2 nAChRs by cell surface biotinylation was performed as described previously (Kuryatov et al., 2005) with minor modifications. A detailed description is provided in the Supplemental Materials. Measurement of [ 3 H]epibatidine binding in subcellular compartments was achieved by fractionating transfected HEK293 cells with a subcellular fractionation kit (Pierce Biotechnology, Rockford, IL) according to the manufacturer's instructions.
Immunocapture of nAChRs and Identification of ReceptorAssociated Proteins by Liquid Chromatography and Tandem Mass Spectrometry. Solubilized nAChRs were captured using M270 epoxy-coated Dynabeads (Invitrogen) coupled to 0.5 mg of mAb295/mg beads, which specifically recognizes b2-nAChRs (Whiting and Lindstrom, 1988) , and the ha4b2 nAChR-associated proteome was identified as described in the Supplemental Methods.
Expression and Recording of a4b2 nAChRs in X. laevis Oocytes. Expression and electrophysiological recording of ha4(RV)b 2 nAChRs in X. laevis oocytes was conducted essentially as reported previously (Williams et al., 2011) . Agonist application was set at 8 seconds during recording, with 241-second washes in between stimulations. Responses to agonist are reported as percent of maximum response 6 S.E.M. to limit interexperimental variation or differences in receptor expression because of effects of the ha4 polymorphisms related to nAChR assembly.
Data Analysis. For electrophysiological studies, normalized response values were used to generate agonist concentration-response curves. The resulting curves were fit to two-and four-parameter regular hyperbolic equations followed by F-tests to determine the statistical preference for one or two distinct activation components, respectively. Curve fit equations were: y 5 ax/b 1 x, where (y) is recorded activity with maximal activation (a) and agonist EC 50 (b) for a single component (2-parameter) , and y 5 (ax/b 1 x) 1 (cx/d 1 x), where (y) is recorded activity with high-sensitivity maximal activation (a), EC 50 (b), and lower sensitivity (c) with EC 50 (d) (4-parameter) .
SPSS 21.0 and SigmaPlot 12.0 (2012 and 2011, respectively) were used for statistical analysis and data organization. Statistical significance was determined with one-or two-way analysis of variance or Student's t test, depending on the experimental design, with a confidence interval set at 95%.
Results
Effect of ha4 Variants on a4b2 nAChR Expression. To identify any differences in efficiency of receptor assembly due to polymorphisms in the human a4 subunit (ha4, gene symbol CHRNA4), HEK293 cells were transfected with 1 mg of hb2 cDNA per 250,000 cells and 0.01, 0.1, or 1 mg of ha4 cDNA, and binding of 2 nM [ (Table 1) . Transient transfection with large excesses of ha4 nAChR cDNA with a fixed concentration of hb2 cDNA results in a sharp inverted-U relationship with respect to binding sites produced. To avoid this, we confined our analysis to the ratios of a4:b2 cDNA that produced a proportional increase in binding sites per microgram a4 cDNA. The estimated 1/2 maximal cDNA concentration for expression did not vary across the a4 variants examined, but there was a significant effect of a4 variant on estimated maximal expression, with the a4P451L variant showing a 38% decrease in binding relative to control (Supplemental Fig. S1 ). All subsequent experiments with transient transfection of ha4 and hb2 in HEK293 cells, including those for receptor upregulation, used a 1:1 ratio of a4:b2 subunit cDNA.
HEK293 cells were transfected with ha4 and hb2 cDNA and binding was measured across a range of [ 3 H]epibatidine concentrations (Table 2 ). There was a significant effect of ha4 Effects of ha4 Variants on a4b2-nAChR Upregulation and Plasma Membrane Levels in Response to Nicotine Exposure. a4b2 nAChRs are upregulated by long-term exposure to nicotine (reviewed by Lester et al., 2009) . To test for sensitivity and extent of nicotine-induced receptor upregulation, nicotine (0, 3, 10, 30, 100, 1000, and 3000 nM) was added to the wells with ha4 and hb2 cDNAs, and the cells were incubated overnight. After 24-hour nicotine exposure, all ha4 variants showed concentration-dependent and saturable upregulation of [ 3 H]epibatidine binding sites ( Fig. 1A ; Table 3 ). There was no significant difference in either maximal upregulation by nicotine or EC 50 . Converting the data from femtomoles per milligram to percentage of control (no nicotine) to produce a measure of fold-increase reveals significant differences in the ability of nicotine to upregulate a4b2 nAChRs depending on the ha4 variant (Fig. 1B ). Dunnett's post hoc analysis shows that nicotine upregulates [ 3 H]epibatidine binding in a4P451Lb2-transfected HEK293 cells to a greater extent than nAChRs, incorporating the other a4 variants examined with no significant effect on EC 50 (Table 4) .
To determine the distribution of [ 3 H]epibatidine binding sites in cells, surface receptors were biotinylated prior to cell lysis, and binding to biotinylated receptors was quantified.
Measuring [
3 H]epibatidine binding prior to solubilization in phosphate-buffered saline supplemented with 2% Triton X-100 quantitates all available binding sites (including immature and intracellular pools of receptors), whereas avidin capture of biotinylated receptors from detergent extracts enables detection of plasma membrane nAChRs. Under control conditions, there are fewer total a4P451Lb2 nAChRs compared with the other variants ( Fig. 2A) , but similar levels of plasma membrane binding sites (Fig. 2C) . The deficient expression of [ 3 H]epibatidine binding in cells transfected with a4P451L does not reflect a deficit in cell surface a4P451Lb2 nAChRs. After treatment with 1 mM nicotine for 24 hours, significant upregulation of [ 3 H]epibatidine binding sites was observed in both total and surface receptor pools of all a4 variants ( Fig. 2C ; Table 5 ). As observed with surface expression at baseline, the extent of upregulation measured as fold change relative to control was much greater in nAChRs containing the ha4-P451L variant (Fig. 2, B and D, statistical test results are presented in Supplemental Section 2).
Effects of ha4 Variants on Associated Proteins and Phosphorylation Patterns Identified by Tandem Mass Spectrometry. Eluted a4b2 nAChR complexes were enriched for phosphorylated peptides prior to LC-MS/MS analysis to split each group into phospho-enriched (Phospho) and flow-through (FT) sets, and both sets were analyzed to identify phosphorylated residues of peptides in the MS/MS spectra. We hypothesize that because protein kinases and phosphatases target specific residues in the M3-M4 loop (Pollock et al., 2009) , the rare variants examined in this study might affect the accessibility of these sites. From the initial lists of identified proteins for each ha4 variant, we used a protein-exclusion process to refine the apparent interactomes. Obvious contaminant proteins (keratins, dermicidins, hornerins) were excluded. Because the nAChRs were isolated from solubilized protein extracts prepared from whole cells, some nuclear and mitochondrial proteins were also identified that would normally not be expected to interact with a4b2 nAChRs, and these proteins were also excluded from further consideration. Fig.  S3 ), indicating that the association of importin isoforms with a4P451L does not result in nuclear import of a4b2 nAChRs but instead reflects inappropriate protein/protein interactions that could be expected to influence receptor assembly and posttranslational modification.
Analysis of the 270-amino acid sequence of the M3-M4 intracellular loop of the ha4 nAChR subunit with NetPhos 2.0 (www.cbs.dtu.dk) identifies 17 potential serine phosphorylation sites. None of the a4 variants examined in this study are predicted to affect any of these 17 sites; however, there was a significant discrepancy in the phosphorylation patterns of the identifiable serine residues across the four a4 variants. Consistent with previous studies (Pollock et al., 2007) , we observed phosphorylation of serine residues only on the M3-M4 loop of the a4 subunit ( Table 6 ). Proteolysis of the ha4 subunit by trypsin and LysC prior to LC-MS/MS restricts the absolute coverage of the receptor by producing peptide fragments too small to be unambiguously assigned, and so we anticipated missing 8 of 17 possible phosphorylation sites. There was no difference in the peptide sequence coverage of the M3-M4 loop for the common ha4 variant compared with the a4R336C and a4R487Q variants, so differences in phosphorylation state of identified serine residues are not likely because of differential sequence coverage. The identification of the phosphorylation state of serines in the M3-M4 loop of a4P451L was not possible, because its coverage was insufficient for effective analysis.
Electrophysiological Characterization of a4 Variants. We expressed ha4 variants a4R336C, a4P451L, and a4R487Q with human b2 in X. laevis oocytes and recorded currents elicited by application of nAChR agonists. With equal amounts of ha4 and hb2 cRNA, activation of common variant a4b2 with ACh produced the predicted biphasic concentration-response curve (Table 7) , indicating the presence of nAChRs with high sensitivity to ACh (HS) and a lower sensitivity component (LS), as has been described previously (Marks et al., 2010) . The other ha4 variants (a4R336C, a4P451L, a4R487Q) all had ACh concentration-response curves that favored the activation of a single HS component. The calculated potency of ACh for HS a4b2 activation was similar across variants, indicating that these variants in the a4 subunit do not appreciably affect sensitivity to activation by ACh but limit the stoichiometry of assembled nAChRs to the HS form of a4 2 b2 3 . Nicotine produces similar concentration-response relationships as ACh (Table 8) , with the exception that the HS form of common variant a4b2 is more prominently activated, with no change in potency, when nicotine is used as the agonist. (Calculated activation parameters are found in Tables 7 and 8; Fig. 3.) Because the subunit composition and stoichiometry of a4b2 nAChRs affects their functional profiles, we expressed the a4 variants as concatamers (a4-b2 dimers) to isolate the two defined stoichiometries and determine whether any effects of a4 variant were apparent when receptor assembly is experimentally constrained. Agonist-evoked responses from a4b2 nAChRs assembled with concatenated subunits (as described in Zhou et al., 2003) largely confirmed our hypothesis that ha4 rare variants will affect receptor assembly. In particular, a4P451L shows a reduced ability to assemble as an LS receptor [a4 3 b2 2 ] even when introduced into a concatamer, and a4R336C forces assembly of both HS and LS stoichiometries under every condition examined (full concentration-response curves and parameters of concatenated receptor experiments are found in Supplemental Figs. S4 and S5, and Table S3 , respectively; a detailed description of receptor concatamer experiments is presented in Supplemental Materials).
Effects of 24-hour Nicotine Exposure on Activation Parameters of a4 Variants. Prolonged nicotine exposure promotes the production of HS nAChRs in heterologous systems expressing human a4b2 nAChRs (Kuryatov et al., 2005) . Because the a4 variants appear to alter the stoichiometry of a4b2 nAChRs, we examined a4b2 nAChR activation by ACh and nicotine after oocytes were incubated with 1 mM nicotine for 24 hours. The effects of nicotine exposure were strikingly divergent according to ha4 variant ( Fig. 4A ; Tables 9 and 10 ). Consistent with previous reports, nicotine incubation shifted the concentration-response curve for ACh to a single HS component for common variant a4b2 nAChRs, indicating that exposure to nicotine (1 mM) favors the production of a4b2 nAChRs with the a4 2 b2 3 stoichiometry. In contrast, nicotine exposure shifted the potency of ACh to a significant degree in the a4R336C variants, resulting in the appearance of a substantial LS response profile. This Downloaded from effect appears to reflect the preferential assembly of LS a4R336Cb2 nAChRs after prolonged nicotine exposure, an effect in striking contrast to what is routinely observed with the common variant of ha4. Nicotine exposure did not affect the ACh concentration-response profile for a4P451L, apart from a slight decrease in the overall magnitude of the response (likely due to nicotine-mediated desensitization). The a4R487Q variant retained both HS and LS components after 24-hour nicotine exposure, indicating a decrease in the preferential assembly of HS a4b2 nAChRs in the presence of nicotine. Both control and P451L a4 variants maintained a single HS concentration-response profile in response to acute nicotine challenge after nicotine exposure, whereas the R336C and R487Q a4 variants showed the same biphasic responses as observed before 24-hour nicotine exposure (Fig.  4B ). Incubation of oocytes transfected with the a4R336C variant with nicotine for 24 hours had the same effect on nicotine-evoked currents as observed with ACh, revealing a shift in agonist potency that produced a large LS response.
Representative traces for agonist-evoked inward currents through a4R336Cb2 and common variant a4b2 nAChRs after 24-hour nicotine exposure are shown in Fig. 5 . These results show that whether ACh (Fig. 5A ) or nicotine ( Fig. 5B ) is used as the agonist, a4R336Cb2 nAChRs are substantially less sensitive to agonist activation after 24-hour nicotine exposure than common variant a4b2 nAChRs.
Discussion
We examined the effects of rare CHRNA4 variants on expression, protein/protein interactions, and activation parameters of a4b2 nAChRs. We observed significant effects of these rare a4 variants on nAChR binding site expression and upregulation by nicotine. Most importantly, the a4 variants also altered the nAChR interactome and the parameters of a4b2 nAChR activation by ACh and nicotine and resulted in significant shifts in concentration-response profiles both under control conditions and after a 24-hour exposure to nicotine, indicating that smoking could alter the properties of a4b2 nAChRs in humans carrying these rare genetic variants.
nAChR subunits all possess a large intracellular loop between the M3 and M4 transmembrane domains. The a4 nAChR subunit has the largest (270-amino acids long) M3-M4 loop, and this domain is pivotal in nAChR assembly and functional modulation (Harkness and Millar, 2002; Kuo et al., 2005; Kracun et al., 2008; Tsetlin et al., 2011) . The loop is predicted to be largely unfolded, existing as a series of linear interaction motifs (Kukhtina et al., 2006) . The a4 polymorphisms examined in this study (R336C, P451L, R487Q) all occur within the M3-M4 loop at amino acid residues that are 100% conserved across humans, mice, rats, and chickens, suggesting that these rare variants will affect one or more elements of a4b2 nAChR maturation, expression, and function.
Maximal nAChR production was significantly affected by a4 variant: the a4R487Q variant produced significantly more [ 3 H]epibatidine binding sites when cDNA concentration was maximal, and a4P451L produced significantly fewer nicotinic binding sites. The a4R336C polymorphism was equivalent to the common variant under these conditions. The estimates for a4 cDNA-dependent a4b2 nAChR production were confined to ratios of a4:b2 that yielded concentration-dependent increases in binding sites, as extreme ratios of a4:b2 can produce sharp declines in receptor assembly. Although this restricted curve does not show the absolute saturation of binding site production as a function of a4 cDNA concentration, it does provide accurate estimates of the differences in binding sites produced across the a4 variants examined. Eliminating ER retention motifs in the b2 nAChR enhances nAChR transport from the ER, and the effect of the a4R487Q variant is consistent with accelerated nAChR assembly because of enhanced ER transport (Srinivasan et al., 2011) , considering the proximity of this variant to an established RxR retention motif in the ha4 subunit. The a4P451L variant introduces a peroxisome targeting motif (PTS) and eliminates a highly conserved (100% across humans, rats, mice, and chickens) diproline motif. The decrease in [ binding sites observed with a4P451L is consistent with the possibility that introducing a PTS results in mistargeting of a4 subunits, limiting the total number of pentameric a4b2 nAChRs produced. Although other interpretations are possible, the current observations provide a context for future studies. The a4R336C variant lost a putative 14-3-3 binding motif, but had no effect on the concentration dependence for cDNA effects on nAChR production, which was somewhat unexpected, given the role of 14-3-3 binding in nAChR trafficking (Jeanclos et al., 2001) . Interestingly, despite these differences in assembly across variants, the number of a4b2 nAChRs that were expressed on the cell surface was not affected by any of these a4 variants. Upregulation of a4b2* nAChRs by long-term exposure to nicotine has been suggested to play a role in the development/ maintenance of nicotine dependence and has been observed repeatedly both in vitro and in vivo in rodents and human smokers (Staley et al., 2006; Lester et al., 2009 ). Nicotine increased [ 3 H]epibatidine binding to nAChRs containing all a4 variants examined; however, although production of a4b2 nAChRs is deficient for a4P451L under control conditions, incubation with nicotine effectively "normalized" its ability to produce [ Upregulation of nAChRs has been attributed to the ability of nicotine to bind to and stabilize nascent nAChRs in the process of assembly and maturation in the ER and reduce nAChR degradation after insertion into the plasma membrane (Kuryatov et al., 2005; Srinivasan et al., 2011) . This process of pharmacological chaperoning is thought to involve selective stabilization of fully folded nAChR intermediates, rather than to promote the folding of primarily linear peptides (Lester et al., 2009) . The observation that the a4P451L variant produces substantially fewer nAChRs, but that pharmacological chaperoning with nicotine boosts a4P451L assembly with b2 to levels consistent with the a4 common variant is particularly interesting because the P451L substitution removes a highly conserved diproline residue and introduces a novel PTS motif that may mistarget the receptor to the peroxisome or other intracellular compartments. It is possible that a conformational change produced when nascent a4P451Lb2 receptors bind nicotine obscures the recognition of the PTS motif and allows assembly to proceed normally, without mistargeting or preferentially degrading the a4P451Lb2 receptor intermediates. An alternate possibility is that elimination of the diproline residue produces an a4 subunit with more conformational flexibility in the large M3-M4 loop than the common variant and may trigger ERresident chaperoning in a manner that favors rapid degradation in the absence of a stabilized conformation (as would be the case with pharmacological chaperoning by nicotine). Propro motifs tend to produce segments of polypeptides with a constrained conformation (Saha and Shamala, 2012), so eliminating a strong structural constituent motif would be expected to radically alter the position and accessibility of several linear interaction motifs both C-and N-terminal of the disrupted sequence.
The possibility that the a4P451L variant results in ERdependent nAChR degradation is supported by studies that identified a significant association between several rare variants in the a4 nAChR subunit gene, in particular the a4P451L polymorphism, and ALS (Sabatelli et al., 2009 (Sabatelli et al., , 2012 . A study examining an ALS-risk variant of the b4 nAChR subunit (b4R348C) found decreased expression of nAChRs when this variant was coexpressed with ha4, an effect primarily due to decreased ER export of a4b4R348C nAChRs (Richards et al., 2011) . In that study, submicromolar nicotine did not alter the amount of a4b4 plasma membrane expression, so the deficient nAChR production resulting from expression of the b4R348C ALS-risk variant could not be rescued by concentrations of nicotine that normally produce upregulation of nAChRs and typically observed in smoker's blood (Benowitz, 1996) . Unlike the resistance of a4b4 nAChRs to nicotine-initiated upregulation in vitro, we find that nicotine reliably upregulates a4P451Lb2 receptors to levels consistent with the common variant of a4. The a4R487Q variant was also identified as a risk variant for sporadic ALS (Sabatelli et al., 2012) , but with lower frequency than observed for a4P451L. The results presented here demonstrate altered expression of these ALSrisk variants of the a4 nAChR subunit and suggest that this polymorphism clearly demands additional study, both for its effects on nicotine addiction and as a contributor to cellular stress and neurodegenerative disease. The effects of the rare CHRNA4 variants on nAChR binding site production, plasma membrane trafficking, and upregulation by nicotine are further supported by proteomic studies. The a4 subunit of the nAChR is phosphorylated on several sites within the M3-M4 loop (Wecker et al., 2001; Pacheco et al., 2003; Pollock et al., 2007 Pollock et al., , 2009 ), and we augmented the proteomic study by enriching for phosphopeptides prior to LC-MS/MS to identify and profile potential shifts in the phosphorylation state of nAChR subunits and other putatively associated proteins attributable to the presence of the a4 rare variants. The degree of difference relative to the common variant may identify interesting targets for future mechanistic studies and is an indicator of the severity of effect of a single amino acid substitution on the function/assembly/trafficking of a4b2 nAChRs conferred by these rare a4 variants. The a4P451L and a4R336C variants have as many proteins that are unique or missing as are shared with the common a4 variant, whereas the a4R487Q variant is less divergent and only differs by 30%. The interactome of a4P451L in particular highlights the disproportionately large effect this single amino acid substitution has on its associated proteins. The a4P451L variant binds importin subunits without any evidence of nuclear transport, fails to associate with several isoforms of 14-3-3 (a known nAChR chaperone), in the Phospho fraction, and lacks association with the transport protein VAPB in the FT fraction. This lost interaction with VAPB is important, because mutations in VAPB are strongly associated with familial ALS (Nishimura et al., 2004) , adding further support to the potential involvement of the a4P451L variant in the etiology of this neurodegenerative disease.
Electrophysiological measurements of heteromeric nAChRs have demonstrated that functional properties of these receptors are strongly influenced by receptor stoichiometry (Papke et al., 1989) . Experiments that alter the relative expression of individual subunits (Zwart and Vijverberg 1998; Nelson et al., 2003; Moroni and Bermudez, 2006; Gotti et al., 2008) or use concatenated a4 and b2 subunits to force expression of defined subunit arrangements (Zhou et al., 2003) , have demonstrated that functional parameters of a4b2 nAChRs are largely dependent on the position of individual subunits in the pentamer. Overall, a4 2 b2 3 nAChRs are more sensitive to agonists than a4 3 b2 2 nAChRs (Nelson et al., 2003) , and both stoichiometries of a4b2 can be observed in the Fig. 4 . Electrophysiological recordings of a4b2 nAChRs expressed in X. laevis oocytes activated by acetylcholine following 24 hour exposure to 1 mM nicotine. (A) The concentration-response curve for the common a4 variant (d) shifts from biphasic to monophasic, high-sensitivity activation by acetylcholine. The concentration-response curve for a4P451L (.) remains monophasic and high-sensitivity activation. The curves for a4R336C (s) and a4R487Q (n) shift from a monophasic, high-sensitivity relationship to biphasic activation, with both variants gaining lowsensitivity activation components. (B) Electrophysiological recordings of a4b2 nAChRs expressed in X. laevis oocytes activated by nicotine after 24-hour exposure to 1 mM nicotine. The concentration-response curve for the common a4 variant (d) remains a monophasic, high-agonist sensitivity relationship, as does the curve established for a4P451L (.). The curves for a4R336C (s) and a4R487Q (n) shift from a monophasic, high-sensitivity component to biphasic curves with added low-sensitivity components. The size of the LS component is particularly large for a4R336C. , 1999, 2007) . The current studies indicate that a4 polymorphisms may shift the ratio of a4b2 nAChR assembly to favor the production of HS receptors. Consistent with this possibility, we see that ACh concentration-response curves for the common a4 variant show both HS and LS components, indicative of the presence of both a4b2 stoichiometries, whereas a4 rare variants produced monophasic, high-sensitivity ACh concentrationresponse curves when expressed in X. laevis oocytes. Both X. laevis oocyte and HEK 293 experiments suggest that a4P451L preferentially assumes the a4 2 b2 3 HS stoichiometry, likely due to decreased efficiency of a4 subunit incorporation. We did not, however, expect the same result for a4R336C and a4R487Q, which showed little difference relative to the common variant of a4 in nAChR expression or subcellular distribution when measured in transfected HEK293 cells. When expressing the receptor subunits as concatamers to restrict stoichiometry, the a4P451L variant produced HS receptors even when conditions strictly supported the assembly of LS a4b2 nAChRs, supporting the assertion that incorporation of this a4 variant is inefficient. The effects of a4R336C as a concatamer are more difficult to interpret, because both a4b2 stoichiometries were produced regardless of experiment conditions. Upregulation of a4b2 nAChRs by nicotine exposure preferentially produces the HS form of the receptor (Kuryatov et al., 2005) . After 24-hour nicotine, the common variant produced an ACh concentration-response curve with a monophasic, HS component. The a4P451L variant only produced HS nAChRs under baseline conditions and continued to produce only HS receptors after nicotine treatment. The a4R336C and a4R487Q variants, by contrast, responded to nicotine exposure by producing LS components in response to both ACh and nicotine. This effect opposes the actions of those variants on receptor assembly in the absence of nicotine. A confounding factor comes from the observation that X. laevis oocytes act as "nicotine sponges" during incubation with nicotine and release desensitizing concentrations of nicotine into superfusion buffer during recording (Jia et al., 2003) . However, HS and LS forms of a4b2 nAChRs do not differ in their sensitivity to steady-state desensitization with subactivating concentrations of nicotine (Marks et al., 2010) , so any differences in function observed after 24-hour nicotine across the a4 variants are due to effects conferred by the variants themselves.
A growing body of epidemiologic evidence suggests nicotine sensitivity is a potent determinant of smoking liability (Pomerleau et al., 2003; Hu et al., 2006) . Furthermore, investigations with mouse strains led to the discovery of naturally occurring polymorphisms in nAChR subunits that influenced sensitivity to nicotine (Stitzel et al., 2000) . One of these naturally occurring mouse polymorphisms was found in the intracellular loop of the a4 subunit (a4A529T) (Stitzel et al., 2001) . Expression of the a4A529 variant increases sensitivity to nicotine, eliminates nicotine conditioned place preference, and produces increased HS a4b2 nAChRs in the midbrain (Wilking et al., 2010) . A smoking risk-associated nAChR polymorphism that occurs in the a5 nAChR subunit (Bierut et al., 2008) introduces an amino acid substitution in the intracellular loop of a5 (a5D397N; D398N for mouse sequence) and results in decreased function of a4b2 and a3b4 nAChRs (Bierut et al., 2008; Kuryatov et al., 2011) . Thus, expression of nAChRs in the CNS that favor high-agonist sensitivity assemblies appear to be associated with a decrease in risk for nicotine dependence, whereas expression of lowersensitivity receptors increases risk of nicotine dependence.
Conclusions
The current observations that certain rare a4 nAChR subunit variants that are apparently underrepresented among dependent smokers are more likely to assemble in the high sensitivity conformation supports the link between agonist sensitivity of neuronal nAChRs with the likelihood of nicotine dependence and addiction-related behaviors. We have shown that single amino acid substitutions in the large M3-M4 loop of the a4 nAChR subunit can result in large changes in receptor number, stoichiometry, and associated proteins. These studies also suggest potential molecular mechanisms by which these effects are produced by the individual mutations. Although our mechanistic grasp of the functional and expression differences for a4R336C and a4R487Q is not complete, changes in intracellular interactions with associated proteins or posttranslational modifications (phosphorylation, glycosylation) may be involved in the effects of these rare a4 nAChR subunit variants. For a4P451L, considerable evidence suggests that deficient assembly in the early maturational stages of the receptor results in the preferential exclusion of a4P451L from the fifth position, resulting in constrained expression of a4 2 b2 3 nAChRs. This mechanism is consistent with reports indicating that a4P451L is a risk variant for sporadic ALS, and such association may result from enhanced ER stress due to deficient receptor assembly. Human β2 cDNA for HEK 293 cell transfection was kindly provided by Dr. Jon Lindstrom (University of Pennsylvania) in a pRc/CMV expression vector (Invitrogen), cloned as described previously (Wang et al, 1998) . Verified mutants were amplified by inoculating 400 ml of sterile LB supplemented with 100u/ml ampicillin with 1 ml of the verified culture. cDNA was purified from the large cultures with a Qiagen Endo-free Maxi-prep kit.
Cell Culture and Transfection:
Transient transfections were performed with Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Briefly, cells were plated at an initial density of 50,000/cm 2 in DMEM+10% heat-inactivated fetal bovine serum (FBS), 100u/ml penicillin, 100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B and maintained at 37 o C and 5% CO 2 . Cells were allowed to reach ~90% confluence before transfection (typically ~96 hours). On the day of transfection, media was removed and cells rinsed once with warm DMEM+10% FBS, and covered with fresh DMEM+10% FBS. cDNA was mixed with Lipfectamine 2000 (7 µl/μg cDNA) in Optimem (200 μl/μg cDNA) and incubated at room temp for 30 min. The Optimem:Lipofectamine:cDNA mixture was gently layered onto the media and cells were returned to the incubator. Cells were harvested 24 hr following transfection. 
Cell surface biotinylation and biotinylated nAChR capture:
Briefly, HEK 293 cells were grown to ~80% confluence in 6-well culture plates and transfected as On assay day, cell samples were thawed at 23 o C and vigorously resuspended in 0.1x binding buffer.
Aliquots of this suspension were taken for measurement of [ 
Enzyamtic digestion, LC-MS/MS, and Phosphopeptide analysis:
The dried protein pellet was dissolved in 12 µl 8M urea, 0.4M ammonium bicarbonate (pH 8.0) prior to reduction using 1.2µl 45mM dithiothreitol (DTT-Thermo Scientific Pierce) and incubating at 37°C for 20 minutes. Alkylation was performed with 1.2µl of 100 mM iodoacetamide (IANSigma-Aldrich) and incubating at ambient temperature for 20 minutes. The urea concentration was decreased to 2M with water and the samples were digested with 3µg lysyl endopeptidase (Wako Chemicals) for 4 hours at 37°C, and then with 3µg of Promega sequencing grade trypsin for 16 hours at 37°C . After digestion, the digests were desalted using UltraMicroSpin™ C18 columns (#SUM SS18V The Nest Group Inc.) and dried under vacuum. The peptide pellets were dissolved in 50µl 0.5% TFA, 50% acetonitrile for phosphopeptide enrichment using titanium dioxide TopTips (Glygen). Each TopTip was washed 3 times (at 2,000 rpm for 1 minute each spin) with 40µl 100% acetonitrile, followed with a 0.2M sodium phosphate pH 7.0, and 0.5% TFA, 50% acetonitrile washes. The digests were then loaded and spun at 1,000 rpm for 1 minute, and then 3,000 rpm for 2 minutes. The phosphopeptides were eluted using 3 washes of 30µl 28% ammonium hydroxide. Both the enriched (Phospho) and non-bound or flow through (FT) peptide fractions were desalted using a C18 ZipTip® (Millipore cRNA was prepared from cDNA clones of human α4 and β2 nAChR subunits in psp64
poly-A vectors. Subunit cRNAs (20 ng each) were injected into stage 5 oocytes and recordings were obtained within 7 days. Voltage-clamp recordings were made using OpusExpress 600A, with 300 µM acetylcholine (ACh) used as a control concentration. Raw data was processed with pClamp10 (Molecular Devices). 
Functional Characterization of hα4β2 Rare Variants as Concatamers
Since the functional parameters of α4β2 nAChRs are strongly dependent on the pentameric arrangement in which they assemble, we tested the three rare α4 variants as components of nAChR concatamers. Concatenated subunit dimers (α4-β2) expressed in Xenopus oocytes either alone or with additional free α or β subunits reliably assemble into defined stoichiometries. We expected that constraining nAChR stoichiometry by expressing the rare α4 variants as part of a concatenated dimer with β2 would allow measures of functional parameters of HS and LS forms in isolation. Surprisingly, curve-fit calculations of the concentration-response relationships for ACh were not uniform, and under certain conditions the presence of two distinct activation components were observed. For (α4R336C-β2)+β2, the ACh concentration-response curve shows the presence of both HS and LS components, even though the mix of concatamer with free β2 typically produces a pure HS population of nAChRs (Table S3A ). For (α4R336C-β2)+α4R336C, again we observed a concentration-response profile with both HS and LS components ( Figure S4A ). Instead, (α4P451L-β2)+β2, reliably produced a single HS activation profile, whereas (α4P451L-β2)+α4P451L, resulted in both HS and LS ACh responses ( Figure   S4B ). Finally, either (α4R487Q)+α4R487Q or +β2, produces a uniform population of LS or HS activation components, respectively ( Figure S4C ). In contrast, there was only a single activation component in response to nicotine challenge for each α4 rare variant ( Figure S5 , Table S3B ).
Concatenated α4-β2 dimers with the addition of free α4 or β2 subunits normally produce highly constrained expression of LS or HS receptors (as it did in the case of α4R487Q). With activation of α4R336C and α4P451L concatamers by ACh, there was still a significant biphasic concentration-response profile. This effect was absent when nicotine was applied as the agonist, probably because of greater channel blockade by nicotine at concentrations >30μM. We hypothesize that assembly of α4P451L is so inefficient that a significant portion of the concatamers form dipentamers rather than incorporate free α4P451L subunit. When free β2 is added to the α4P451L-β2 concatamer, by contrast, HS receptors are assembled as expected.
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